Michael J. Fox Foundation's Rapid Response Innovation Awards Hit Mid-2009 With More Than $1 Million Funded in High-risk/High-reward Approaches to Parkinson's Disease

“Rapid Response enables us to assess the best new ideas in real time, quickly vet their potential, and move the most promising ones to the next level fast,” said Katie Hood, CEO of MJFF. “This reflects our commitment to keep fresh ideas flowing into the Parkinson’s therapeutic pipeline, as well as our recognition that when great research ideas have to wait for a program deadline, so do PD patients — a status quo we are determined to improve on.”